Christopher Hill

Christopher Hill

Amministratore Delegato presso ADAPTIMMUNE THERAPEUTICS PLC
46 anni
Finance
Health Technology
Commercial Services

Profilo

Christopher James Hill is currently Director, Chief Executive & Financial Officer at Adaptimmune Therapeutics Plc since 2025.
Mr. Hill is also Director at Cjh Financial LLC and Connexin Therapeutics Ltd, and a Member of The Institute of Chartered Accountants in England & Wales.
Former roles include Director at OXECO Ltd., CFO, Secretary & Executive Director at Abaco Capital Plc, Director at Oxford Pharmascience Ltd. from 2013 to 2020, Secretary, Director, Finance Director & Controller at Quoram Ltd. in 2013, Group Financial Controller at ORA Capital Partners Ltd., and Chief Financial & Operating Officer at Istesso Ltd. from 2021 to 2025.
Education includes an undergraduate degree from Leeds Beckett University, conferred in 2001.

Posizioni attive di Christopher Hill

SocietàPosizioneInizio
ADAPTIMMUNE THERAPEUTICS PLC Amministratore Delegato 14/11/2025
Corporate Officer/Principal -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -

Precedenti posizioni note di Christopher Hill

SocietàPosizioneFine
Direttore Finanziario/CFO 09/09/2025
Direttore/Membro del Consiglio 31/12/2020
Direttore/Membro del Consiglio 30/04/2020
QUORAM PLC Direttore Finanziario/CFO -
Comptroller/Controller/Auditor -
Vedi nel dettaglio l'esperienza di Christopher Hill

Formazione di Christopher Hill

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

84

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private11

Finance

Commercial Services

Consumer Services

Commercial Services

Finance

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Finance

  1. Mercati
  2. Insiders
  3. Christopher Hill